| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicine, University of Auckland, Auckland 1020, New Zealand
Address all correspondence and requests for reprints to: Dr. Mark Bolland, Osteoporosis Research Group, Department of Medicine, University of Auckland, Private Bag 92 019, Auckland 1020, New Zealand. E-mail: m.bolland{at}auckland.ac.nz.
Although primary hyperparathyroidism is frequently asymptomatic, it has been associated with an increased prevalence of hypertension, insulin resistance, dyslipidemia, cardiovascular mortality, and cancer. Previously we reported that patients with primary hyperparathyroidism are heavier than age-matched controls. Increased body weight could contribute to the association between primary hyperparathyroidism and these extraskeletal complications. We searched MEDLINE for English language studies published between 1975 and 2003 that reported body weight or body mass index in subjects with primary hyperparathyroidism and a healthy age- and sex-comparable eucalcemic control group. Seventeen eligible studies were identified. Subjects with primary hyperparathyroidism were 3.34 kg (95% confidence interval, 1.97–4.71; P < 0.00001) heavier than controls in 13 studies reporting body weight. In four studies reporting body mass index, subjects with primary hyperparathyroidism had an increased body mass index of 1.13 kg/m2 (–0.29 to 2.55; P = 0.12) compared with controls. Standard mean difference analysis showed that subjects with primary hyperparathyroidism had an increased weight or body mass index of 0.3 SD (0.19–0.40; P < 0.00001) compared with controls. We conclude that patients with primary hyperparathyroidism are heavier than their eucalcemic peers, and that increased body weight may contribute to the reported associations between primary hyperparathyroidism and some extraskeletal complications.
This article has been cited by other articles:
 |
|
 |
|
  S. E. Christensen, P. H Nissen, P. Vestergaard, L. Heickendorff, L. Rejnmark, K. Brixen, and L. Mosekilde Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism Eur. J. Endocrinol., December 1, 2008; 159(6): 719 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P Reis, D. von Muhlen, and E. R Miller III Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol., July 1, 2008; 159(1): 41 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Nakchbandi, R. Lang, B. Kinder, and K. L. Insogna The Role of the Receptor Activator of Nuclear Factor-{kappa}B Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 967 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Siilin, J. Rastad, O. Ljunggren, and E. Lundgren Disturbances of Calcium Homeostasis Consistent with Mild Primary Hyperparathyroidism in Premenopausal Women and Associated Morbidity J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 47 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Reinehr, G. de Sousa, U. Alexy, M Kersting, and W. Andler Vitamin D status and parathyroid hormone in obese children before and after weight loss Eur. J. Endocrinol., August 1, 2007; 157(2): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults Diabetes Care, June 1, 2007; 30(6): 1549 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ayturk, A. Gursoy, N. Bascil Tutuncu, D. T. Ertugrul, and N. Guvener Demirag Changes in Insulin Sensitivity and Glucose and Bone Metabolism over Time in Patients with Asymptomatic Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4260 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Moosgaard, P Vestergaard, L Heickendorff, F Melsen, P Christiansen, and L Mosekilde Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol., August 1, 2006; 155(2): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hagstrom, E. Lundgren, J. Rastad, and P. Hellman Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol., July 1, 2006; 155(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Grey, M. Bolland, and I. R. Reid Evaluation and Treatment of Primary Hyperparathyroidism JAMA, December 7, 2005; 294(21): 2699 - 2700. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Panidis, C. Balaris, D. Farmakiotis, D. Rousso, A. Kourtis, V. Balaris, I. Katsikis, V. Zournatzi, and E. Diamanti-Kandarakis Serum Parathyroid Hormone Concentrations Are Increased in Women with Polycystic Ovary Syndrome Clin. Chem., September 1, 2005; 51(9): 1691 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakhaee and N. M. Maalouf Dietary Calcium, Obesity and Hypertension--The End of the Road? J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4411 - 4413. [Full Text] [PDF]
|
|
|
|
|
|
M. B. Snijder, R. M. van Dam, M. Visser, D. J. H. Deeg, J. M. Dekker, L. M. Bouter, J. C. Seidell, and P. Lips Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4119 - 4123. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
